drugset / Trial / NCT00694798
Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder
NaSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the response rate of this treatment (Mw) in patients with BCG refractory superficial transitional cell carcinoma. Other objectives include detecting the effect of Mw on Time to Tumor progression and evaluating safety.
Timeline
- Start
- 2008-10
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycobacterium w | Vaccine | — | — |